Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-01 |
filingDate |
1991-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1993-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34c781f775f0dfb54f185b8e925668ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ce63d76036665c208a53dd7e36bcf23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a56cd250a316a33ab7ad6f1123ef5af2 |
publicationDate |
1993-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5190950-A |
titleOfInvention |
Antagonists of immunosuppressive macrolides |
abstract |
A method for the modification of treatment of an immuno regulatory disorder or disease with an FK-506-type immunosuppressive macrolide comprising the administration to a mammalian species in need of such modification of an effective amount of a compound of the formula I. <IMAGE> I |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5532248-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021248189-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004209911-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880280-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5932243-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7025975-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6565859-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-408520-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-408521-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5693648-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5344925-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5349061-A |
priorityDate |
1990-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |